A novel MYH7 mutation with prominent paraspinal and proximal muscle involvements.

SET binding factor 1 (SBF1) mutation causes Charcot-Marie-Tooth disease type 4B3.

Proximal dominant hereditary motor and sensory neuropathy is caused by a mutation in TRK fused gene.

Inhibition of thrombin-induced microglial activation and NAPDH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo.

Dual role of ERK2/NF-kB signaling in TRAIL sensitivity.

Doxycycline potentiates the anti-proliferation effects of gemcitabine in pancreatic cancer cells.

p53‐mediated regulation of mitochondrial dynamics plays a pivotal role in the senescence of various normal cells as well as cancer cells.

HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction.

Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine.

Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine.